Although GSK2830371 efficiently suppressed growth of breast cancer cells with amplified PPM1D and wild type TP53, it did not affect viability of MCF7 cells suggesting that inhibition of WIP1 alone may not be sufficient to eradicate tumor cells. The gene discussed is TP53; the disease is breast carcinoma.